Munich Re's troubled Ergo explores digital push in China
FRANKFURT, April 28 Ergo, Munich Re's troubled primary insurance company, is making a digital push in the massive Chinese market.
Dec 15 Aethlon Medical Inc
* Aethlon medical inc - will seek to demonstrate that hemopurifier can simultaneously capture all three viruses
* Aethlon announces initiation of sepsis-related virus study Source text for Eikon: Further company coverage:
April 28 The U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other blood disorders, the agency said on Friday.